West Hill Financial Advisors, Inc. Abbott Laboratories Transaction History

West Hill Financial Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $9,856 - $10,886	-90 Reduced 4.65%	1,847 $209,000
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $38,330 - $46,920	-425 Reduced 17.99%	1,937 $213,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $8,406 - $10,086	-88 Reduced 3.59%	2,362 $228,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $19,275 - $22,687	-199 Reduced 7.51%	2,450 $248,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $19,012 - $22,304	200 Added 8.17%	2,649 $290,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.04%	2,449 $237,000
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $114 - $139	1 Added 0.04%	2,448 $290,000
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.04%	2,447 $289,000
Q1 2021 Oct 13, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.04%	2,446 $293,000
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $256,725 - $279,756	2,445 New	2,445 $268,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of West Hill Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on West Hill Financial Advisors, Inc. with notifications on news.